SIMILAR PATTERNS OF AMINO ACIDS FOR 4U14_A_0HKA2000_1
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1a6c | TOBACCO RINGSPOTVIRUS CAPSID PROTEIN (Tobaccoringspot virus) |
PF03391(Nepo_coat)PF03688(Nepo_coat_C)PF03689(Nepo_coat_N) | 5 | ILE A 170THR A 470ALA A 135ASN A 133CYH A 129 | None | 1.38A | 4u14A-1a6cA:undetectable | 4u14A-1a6cA:22.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1by7 | PROTEIN (PLASMINOGENACTIVATORINHIBITOR-2) (Homo sapiens) |
PF00079(Serpin) | 5 | ILE A 114THR A 177ALA A 201ALA A 358ASN A 200 | None | 1.48A | 4u14A-1by7A:undetectable | 4u14A-1by7A:21.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1cu1 | PROTEIN(PROTEASE/HELICASENS3) (Hepacivirus C) |
PF02907(Peptidase_S29)PF07652(Flavi_DEAD) | 5 | ILE A 288SER A 211THR A 416ALA A 233TYR A 270 | NonePO4 A 800 (-4.6A)NoneNoneNone | 1.12A | 4u14A-1cu1A:0.0 | 4u14A-1cu1A:20.71 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1d7w | MYELOPEROXIDASE (Homo sapiens) |
PF03098(An_peroxidase) | 5 | ILE C 413ASP C 142ALA A 63ALA A 61ASN A 66 | None | 1.25A | 4u14A-1d7wC:undetectable | 4u14A-1d7wC:22.22 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1e5m | BETA KETOACYL ACYLCARRIER PROTEINSYNTHASE II (Synechocystissp. PCC 6803) |
PF00109(ketoacyl-synt)PF02801(Ketoacyl-synt_C) | 5 | ILE A 89SER A 85THR A 163ALA A 146ASN A 160 | None | 1.08A | 4u14A-1e5mA:undetectable | 4u14A-1e5mA:22.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1jmz | AMINE DEHYDROGENASE (Pseudomonasputida) |
PF08992(QH-AmDH_gamma)PF09098(Dehyd-heme_bind)PF09099(Qn_am_d_aIII)PF09100(Qn_am_d_aIV)PF14930(Qn_am_d_aII) | 5 | ASP A 93SER A 97THR A 88ALA G 5ALA G 3 | None | 1.46A | 4u14A-1jmzA:undetectable | 4u14A-1jmzA:19.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1sgv | TRNA PSEUDOURIDINESYNTHASE B (Mycobacteriumtuberculosis) |
PF01509(TruB_N)PF09142(TruB_C)PF16198(TruB_C_2) | 5 | ASP A 279THR A 242ALA A 246ALA A 248TYR A 264 | None | 1.48A | 4u14A-1sgvA:undetectable | 4u14A-1sgvA:21.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1szq | 2-METHYLCITRATEDEHYDRATASE (Escherichiacoli) |
PF03972(MmgE_PrpD) | 5 | THR A 229ALA A 225ALA A 224TRP A 98CYH A 57 | None | 1.33A | 4u14A-1szqA:0.0 | 4u14A-1szqA:22.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1tmo | TRIMETHYLAMINEN-OXIDE REDUCTASE (Shewanellamassilia) |
PF00384(Molybdopterin)PF01568(Molydop_binding) | 5 | ASP A 290TYR A 284THR A 251ALA A 255ALA A 257 | None | 1.47A | 4u14A-1tmoA:0.0 | 4u14A-1tmoA:20.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1uzr | RIBONUCLEOTIDEREDUCTASE R2-2 SMALLSUBUNIT (Mycobacteriumtuberculosis) |
PF00268(Ribonuc_red_sm) | 5 | ASP A 72TYR A 110SER A 109ALA A 187TRP A 36 | FE A1292 (-2.5A)NoneNoneNoneNone | 1.42A | 4u14A-1uzrA:2.3 | 4u14A-1uzrA:20.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1v7v | CHITOBIOSEPHOSPHORYLASE (Vibrioproteolyticus) |
PF06165(Glyco_transf_36)PF17167(Glyco_hydro_36) | 5 | ASP A 667TYR A 666TRP A 650THR A 321ALA A 718 | None | 1.35A | 4u14A-1v7vA:undetectable | 4u14A-1v7vA:19.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1zvt | TOPOISOMERASE IVSUBUNIT A (Escherichiacoli) |
PF03989(DNA_gyraseA_C) | 5 | ILE A 622TYR A 602SER A 598ALA A 680ALA A 679 | None | 1.46A | 4u14A-1zvtA:undetectable | 4u14A-1zvtA:18.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2bvt | BETA-1,4-MANNANASE (Cellulomonasfimi) |
PF02156(Glyco_hydro_26) | 5 | ILE A 8ASP A 241TYR A 215ALA A 152ALA A 155 | None | 1.45A | 4u14A-2bvtA:undetectable | 4u14A-2bvtA:22.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2dvl | ACYL-COADEHYDROGENASE (Thermusthermophilus) |
PF00441(Acyl-CoA_dh_1)PF02770(Acyl-CoA_dh_M)PF02771(Acyl-CoA_dh_N) | 5 | THR A 306ALA A 309ALA A 295TRP A 67TYR A 94 | None | 1.49A | 4u14A-2dvlA:3.5 | 4u14A-2dvlA:23.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2gdz | NAD+-DEPENDENT15-HYDROXYPROSTAGLANDIN DEHYDROGENASE (Homo sapiens) |
PF00106(adh_short) | 5 | SER A 123THR A 162ALA A 166ALA A 168ASN A 239 | None | 0.98A | 4u14A-2gdzA:undetectable | 4u14A-2gdzA:20.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2mqd | UNCHARACTERIZEDPROTEIN (Lactobacillusreuteri) |
no annotation | 5 | ILE A 54TYR A 68SER A 69THR A 90ALA A 32 | None | 1.48A | 4u14A-2mqdA:undetectable | 4u14A-2mqdA:15.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2oae | DIPEPTIDYL PEPTIDASE4 (Rattusnorvegicus) |
PF00326(Peptidase_S9)PF00930(DPPIV_N) | 5 | ILE A 325ASP A 327TRP A 335THR A 219ALA A 222 | None | 1.41A | 4u14A-2oaeA:undetectable | 4u14A-2oaeA:20.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2own | PUTATIVEOLEOYL-[ACYL-CARRIERPROTEIN]THIOESTERASE (Lactobacillusplantarum) |
PF01643(Acyl-ACP_TE) | 5 | TYR A 96THR A 3ALA A 6ALA A 8TYR A 111 | NoneNoneGOL A 270 (-3.9A)NoneGOL A 269 ( 3.6A) | 1.27A | 4u14A-2ownA:undetectable | 4u14A-2ownA:18.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2qny | 3-OXOACYL-[ACYL-CARRIER-PROTEIN]SYNTHASE 3 (Mycobacteriumtuberculosis) |
PF08541(ACP_syn_III_C)PF08545(ACP_syn_III) | 5 | ILE A 280SER A 279ALA A 158TYR A 304CYH A 112 | NoneNoneNoneNoneDFD A 760 (-1.6A) | 1.09A | 4u14A-2qnyA:undetectable | 4u14A-2qnyA:22.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3a9g | PUTATIVEUNCHARACTERIZEDPROTEIN (Pyrobaculumaerophilum) |
PF07995(GSDH) | 5 | ASP A 144ALA A 172ALA A 185ASN A 153TYR A 113 | None | 1.30A | 4u14A-3a9gA:undetectable | 4u14A-3a9gA:19.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3fha | ENDO-BETA-N-ACETYLGLUCOSAMINIDASE (Glutamicibacterprotophormiae) |
PF03644(Glyco_hydro_85) | 5 | TYR A 299ALA A 94ALA A 60ASN A 123TYR A 205 | None | 1.36A | 4u14A-3fhaA:undetectable | 4u14A-3fhaA:19.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3qr2 | BASIGIN (Homo sapiens) |
PF13927(Ig_3) | 5 | ILE A 60TYR A 64SER A 70ALA A 2ALA A 25 | None | 1.49A | 4u14A-3qr2A:undetectable | 4u14A-3qr2A:13.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3sut | BETA-HEXOSAMINIDASE (Paenibacillussp. TS12) |
PF00728(Glyco_hydro_20)PF02838(Glyco_hydro_20b) | 5 | ILE A 153SER A 154ALA A 94ALA A 95ASN A 115 | None | 1.30A | 4u14A-3sutA:undetectable | 4u14A-3sutA:22.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3uon | HUMAN M2 MUSCARINICACETYLCHOLINE,RECEPTOR T4 LYSOZYMEFUSION PROTEIN (Escherichiavirus T4;Homo sapiens) |
PF00001(7tm_1)PF00959(Phage_lysozyme) | 5 | ASP A 103TYR A 104ALA A 191TYR A 426CYH A 429 | QNB A1162 (-3.1A)QNB A1162 (-4.0A)QNB A1162 (-3.9A)QNB A1162 ( 4.2A)QNB A1162 ( 4.0A) | 1.49A | 4u14A-3uonA:38.6 | 4u14A-3uonA:73.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3uon | HUMAN M2 MUSCARINICACETYLCHOLINE,RECEPTOR T4 LYSOZYMEFUSION PROTEIN (Escherichiavirus T4;Homo sapiens) |
PF00001(7tm_1)PF00959(Phage_lysozyme) | 12 | ILE A 72ASP A 103TYR A 104SER A 107TRP A 155THR A 187ALA A 191ALA A 194TRP A 400ASN A 404TYR A 426CYH A 429 | NoneQNB A1162 (-3.1A)QNB A1162 (-4.0A)QNB A1162 (-3.4A)QNB A1162 (-4.2A)QNB A1162 (-4.8A)QNB A1162 (-3.9A)QNB A1162 ( 4.0A)QNB A1162 (-4.7A)QNB A1162 (-2.9A)QNB A1162 ( 4.2A)QNB A1162 ( 4.0A) | 0.91A | 4u14A-3uonA:38.6 | 4u14A-3uonA:73.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3uon | HUMAN M2 MUSCARINICACETYLCHOLINE,RECEPTOR T4 LYSOZYMEFUSION PROTEIN (Escherichiavirus T4;Homo sapiens) |
PF00001(7tm_1)PF00959(Phage_lysozyme) | 7 | ILE A 72ASP A 103TYR A 104THR A 190TRP A 400ASN A 404CYH A 429 | NoneQNB A1162 (-3.1A)QNB A1162 (-4.0A)QNB A1162 (-4.3A)QNB A1162 (-4.7A)QNB A1162 (-2.9A)QNB A1162 ( 4.0A) | 1.43A | 4u14A-3uonA:38.6 | 4u14A-3uonA:73.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3uon | HUMAN M2 MUSCARINICACETYLCHOLINE,RECEPTOR T4 LYSOZYMEFUSION PROTEIN (Escherichiavirus T4;Homo sapiens) |
PF00001(7tm_1)PF00959(Phage_lysozyme) | 6 | ILE A 72TYR A 104THR A 190ALA A 194TRP A 400CYH A 429 | NoneQNB A1162 (-4.0A)QNB A1162 (-4.3A)QNB A1162 ( 4.0A)QNB A1162 (-4.7A)QNB A1162 ( 4.0A) | 1.49A | 4u14A-3uonA:38.6 | 4u14A-3uonA:73.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3wwx | S12 FAMILY PEPTIDASE (Streptomycessp. 82F2) |
PF00144(Beta-lactamase) | 5 | ILE A 274SER A 275THR A 70ALA A 60ALA A 356 | None | 1.35A | 4u14A-3wwxA:undetectable | 4u14A-3wwxA:20.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4fdd | TRANSPORTIN-1 (Homo sapiens) |
PF03810(IBN_N)PF13513(HEAT_EZ) | 5 | ILE A 91THR A 144ALA A 148ALA A 151TRP A 126 | None | 1.16A | 4u14A-4fddA:2.1 | 4u14A-4fddA:20.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4gdn | PROTEIN FLP (Staphylococcusaureus) |
PF00144(Beta-lactamase) | 5 | TYR A 190THR A 329ALA A 95ALA A 265ASN A 97 | None | 1.45A | 4u14A-4gdnA:undetectable | 4u14A-4gdnA:20.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homo sapiens) |
PF00001(7tm_1) | 5 | ASP A 103TYR A 104ALA A 191TYR A 426CYH A 429 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)None2CU A 502 ( 3.9A)IXO A 501 (-3.5A) | 1.17A | 4u14A-4mqtA:33.1 | 4u14A-4mqtA:45.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homo sapiens) |
PF00001(7tm_1) | 6 | ASP A 103TYR A 104SER A 107ALA A 191ALA A 194TYR A 426 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)IXO A 501 (-3.4A)NoneIXO A 501 (-3.5A)2CU A 502 ( 3.9A) | 0.99A | 4u14A-4mqtA:33.1 | 4u14A-4mqtA:45.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homo sapiens) |
PF00001(7tm_1) | 7 | ASP A 103TYR A 104SER A 107ALA A 191ASN A 404TYR A 426CYH A 429 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)IXO A 501 (-3.4A)NoneIXO A 501 (-3.0A)2CU A 502 ( 3.9A)IXO A 501 (-3.5A) | 0.99A | 4u14A-4mqtA:33.1 | 4u14A-4mqtA:45.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homo sapiens) |
PF00001(7tm_1) | 6 | ASP A 103TYR A 104SER A 107ALA A 191TRP A 400ASN A 404 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)IXO A 501 (-3.4A)NoneIXO A 501 (-4.6A)IXO A 501 (-3.0A) | 1.23A | 4u14A-4mqtA:33.1 | 4u14A-4mqtA:45.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homo sapiens) |
PF00001(7tm_1) | 5 | ASP A 103TYR A 104TRP A 155ALA A 191TYR A 426 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)IXO A 501 (-3.6A)None2CU A 502 ( 3.9A) | 1.13A | 4u14A-4mqtA:33.1 | 4u14A-4mqtA:45.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homo sapiens) |
PF00001(7tm_1) | 7 | ILE A 72ASP A 103TYR A 104THR A 187ALA A 191ALA A 194TYR A 426 | NoneIXO A 501 (-3.4A)IXO A 501 (-3.7A)NoneNoneIXO A 501 (-3.5A)2CU A 502 ( 3.9A) | 0.98A | 4u14A-4mqtA:33.1 | 4u14A-4mqtA:45.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homo sapiens) |
PF00001(7tm_1) | 8 | ILE A 72ASP A 103TYR A 104THR A 187ALA A 191ASN A 404TYR A 426CYH A 429 | NoneIXO A 501 (-3.4A)IXO A 501 (-3.7A)NoneNoneIXO A 501 (-3.0A)2CU A 502 ( 3.9A)IXO A 501 (-3.5A) | 0.89A | 4u14A-4mqtA:33.1 | 4u14A-4mqtA:45.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homo sapiens) |
PF00001(7tm_1) | 7 | ILE A 72ASP A 103TYR A 104THR A 187ALA A 191TRP A 400ASN A 404 | NoneIXO A 501 (-3.4A)IXO A 501 (-3.7A)NoneNoneIXO A 501 (-4.6A)IXO A 501 (-3.0A) | 1.13A | 4u14A-4mqtA:33.1 | 4u14A-4mqtA:45.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homo sapiens) |
PF00001(7tm_1) | 6 | ILE A 72ASP A 103TYR A 104TRP A 155THR A 187TRP A 400 | NoneIXO A 501 (-3.4A)IXO A 501 (-3.7A)IXO A 501 (-3.6A)NoneIXO A 501 (-4.6A) | 1.34A | 4u14A-4mqtA:33.1 | 4u14A-4mqtA:45.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homo sapiens) |
PF00001(7tm_1) | 6 | ILE A 72ASP A 103TYR A 104TRP A 155THR A 187TYR A 426 | NoneIXO A 501 (-3.4A)IXO A 501 (-3.7A)IXO A 501 (-3.6A)None2CU A 502 ( 3.9A) | 1.03A | 4u14A-4mqtA:33.1 | 4u14A-4mqtA:45.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4n4p | ACYLNEURAMINATELYASE (Mycoplasmasynoviae) |
PF00701(DHDPS) | 5 | ILE A 208THR A 91ALA A 95ALA A 98TYR A 139 | None | 0.94A | 4u14A-4n4pA:undetectable | 4u14A-4n4pA:23.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4q3r | ARGINASE (Schistosomamansoni) |
PF00491(Arginase) | 5 | ILE A 290TRP A 152THR A 137ALA A 306CYH A 332 | None | 1.50A | 4u14A-4q3rA:undetectable | 4u14A-4q3rA:22.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4tpg | PROTON:OLIGOPEPTIDESYMPORTER POT FAMILY (Shewanellaoneidensis) |
PF00854(PTR2) | 5 | ILE A 333TYR A 291THR A 296ALA A 299TYR A 29 | None | 1.48A | 4u14A-4tpgA:2.8 | 4u14A-4tpgA:22.74 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4u16 | MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3 (Escherichiavirus T4;Rattusnorvegicus) |
PF00001(7tm_1)PF00959(Phage_lysozyme) | 6 | ASP A 147TYR A 148THR A 234ALA A 238TYR A 529CYH A 532 | 3C0 A1202 (-3.4A)3C0 A1202 (-3.7A)None3C0 A1202 (-3.5A)3C0 A1202 (-3.7A)3C0 A1202 (-3.6A) | 1.26A | 4u14A-4u16A:36.2 | 4u14A-4u16A:89.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4u16 | MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3 (Escherichiavirus T4;Rattusnorvegicus) |
PF00001(7tm_1)PF00959(Phage_lysozyme) | 12 | ILE A 116ASP A 147TYR A 148SER A 151TRP A 199THR A 231ALA A 235ALA A 238TRP A 503ASN A 507TYR A 529CYH A 532 | None3C0 A1202 (-3.4A)3C0 A1202 (-3.7A)3C0 A1202 (-2.9A)3C0 A1202 (-4.4A)None3C0 A1202 (-3.5A)3C0 A1202 (-3.5A)3C0 A1202 ( 4.0A)3C0 A1202 (-2.9A)3C0 A1202 (-3.7A)3C0 A1202 (-3.6A) | 0.47A | 4u14A-4u16A:36.2 | 4u14A-4u16A:89.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4u16 | MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3 (Escherichiavirus T4;Rattusnorvegicus) |
PF00001(7tm_1)PF00959(Phage_lysozyme) | 7 | ILE A 116ASP A 147TYR A 148THR A 234ASN A 507TYR A 529CYH A 532 | None3C0 A1202 (-3.4A)3C0 A1202 (-3.7A)None3C0 A1202 (-2.9A)3C0 A1202 (-3.7A)3C0 A1202 (-3.6A) | 1.38A | 4u14A-4u16A:36.2 | 4u14A-4u16A:89.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4zky | PYRIDOXAMINE5-PHOSPHATE OXIDASE (Mycolicibacteriumsmegmatis) |
PF01243(Putative_PNPOx) | 5 | ASP A 94TRP A 137ALA A 9ALA A 6TRP A 90 | None | 1.44A | 4u14A-4zkyA:undetectable | 4u14A-4zkyA:15.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5cbm | M17 FAMILYAMINOPEPTIDASE (Plasmodiumfalciparum) |
PF00883(Peptidase_M17) | 5 | ILE A 576SER A 580TRP A 581ALA A 300ALA A 299 | None | 1.49A | 4u14A-5cbmA:undetectable | 4u14A-5cbmA:23.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5cxv | MUSCARINICACETYLCHOLINERECEPTORM1,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M1 (Escherichiavirus T4;Homo sapiens) |
PF00001(7tm_1)PF00959(Phage_lysozyme) | 6 | ASP A 105TYR A 106THR A 192ALA A 196TYR A 404CYH A 407 | 0HK A 501 (-3.0A)0HK A 501 (-3.4A)0HK A 501 (-4.0A)0HK A 501 (-3.6A)0HK A 501 (-3.6A)0HK A 501 (-3.7A) | 1.28A | 4u14A-5cxvA:42.6 | 4u14A-5cxvA:73.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5cxv | MUSCARINICACETYLCHOLINERECEPTORM1,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M1 (Escherichiavirus T4;Homo sapiens) |
PF00001(7tm_1)PF00959(Phage_lysozyme) | 11 | ILE A 74ASP A 105TYR A 106SER A 109THR A 189ALA A 193ALA A 196TRP A 378ASN A 382TYR A 404CYH A 407 | None0HK A 501 (-3.0A)0HK A 501 (-3.4A)0HK A 501 (-3.1A)0HK A 501 (-4.4A)0HK A 501 (-3.9A)0HK A 501 (-3.6A)0HK A 501 (-4.4A)0HK A 501 (-2.8A)0HK A 501 (-3.6A)0HK A 501 (-3.7A) | 0.64A | 4u14A-5cxvA:42.6 | 4u14A-5cxvA:73.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5cxv | MUSCARINICACETYLCHOLINERECEPTORM1,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M1 (Escherichiavirus T4;Homo sapiens) |
PF00001(7tm_1)PF00959(Phage_lysozyme) | 8 | ILE A 74ASP A 105TYR A 106THR A 192TRP A 378ASN A 382TYR A 404CYH A 407 | None0HK A 501 (-3.0A)0HK A 501 (-3.4A)0HK A 501 (-4.0A)0HK A 501 (-4.4A)0HK A 501 (-2.8A)0HK A 501 (-3.6A)0HK A 501 (-3.7A) | 1.25A | 4u14A-5cxvA:42.6 | 4u14A-5cxvA:73.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5cxv | MUSCARINICACETYLCHOLINERECEPTORM1,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M1 (Escherichiavirus T4;Homo sapiens) |
PF00001(7tm_1)PF00959(Phage_lysozyme) | 11 | ILE A 74ASP A 105TYR A 106TRP A 157THR A 189ALA A 193ALA A 196TRP A 378ASN A 382TYR A 404CYH A 407 | None0HK A 501 (-3.0A)0HK A 501 (-3.4A)0HK A 501 (-4.0A)0HK A 501 (-4.4A)0HK A 501 (-3.9A)0HK A 501 (-3.6A)0HK A 501 (-4.4A)0HK A 501 (-2.8A)0HK A 501 (-3.6A)0HK A 501 (-3.7A) | 0.55A | 4u14A-5cxvA:42.6 | 4u14A-5cxvA:73.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5dsg | MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4 (Escherichiavirus T4;Homo sapiens) |
PF00001(7tm_1)PF00959(Phage_lysozyme) | 6 | ASP A 112TYR A 113THR A 199ALA A 203TYR A 439CYH A 442 | 0HK A1201 (-4.0A)0HK A1201 ( 3.2A)OLC A1208 (-4.4A)0HK A1201 (-3.6A)0HK A1201 (-3.6A)0HK A1201 (-3.6A) | 1.38A | 4u14A-5dsgA:41.2 | 4u14A-5dsgA:67.60 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5dsg | MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4 (Escherichiavirus T4;Homo sapiens) |
PF00001(7tm_1)PF00959(Phage_lysozyme) | 11 | ILE A 81ASP A 112TYR A 113SER A 116THR A 196ALA A 200ALA A 203TRP A 413ASN A 417TYR A 439CYH A 442 | None0HK A1201 (-4.0A)0HK A1201 ( 3.2A)0HK A1201 (-3.3A)P6G A1205 (-4.6A)0HK A1201 ( 4.2A)0HK A1201 (-3.6A)0HK A1201 (-4.3A)0HK A1201 (-2.8A)0HK A1201 (-3.6A)0HK A1201 (-3.6A) | 0.71A | 4u14A-5dsgA:41.2 | 4u14A-5dsgA:67.60 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5dsg | MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4 (Escherichiavirus T4;Homo sapiens) |
PF00001(7tm_1)PF00959(Phage_lysozyme) | 8 | ILE A 81ASP A 112TYR A 113THR A 199TRP A 413ASN A 417TYR A 439CYH A 442 | None0HK A1201 (-4.0A)0HK A1201 ( 3.2A)OLC A1208 (-4.4A)0HK A1201 (-4.3A)0HK A1201 (-2.8A)0HK A1201 (-3.6A)0HK A1201 (-3.6A) | 1.45A | 4u14A-5dsgA:41.2 | 4u14A-5dsgA:67.60 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5dsg | MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4 (Escherichiavirus T4;Homo sapiens) |
PF00001(7tm_1)PF00959(Phage_lysozyme) | 11 | ILE A 81ASP A 112TYR A 113TRP A 164THR A 196ALA A 200ALA A 203TRP A 413ASN A 417TYR A 439CYH A 442 | None0HK A1201 (-4.0A)0HK A1201 ( 3.2A)OLC A1208 ( 4.0A)P6G A1205 (-4.6A)0HK A1201 ( 4.2A)0HK A1201 (-3.6A)0HK A1201 (-4.3A)0HK A1201 (-2.8A)0HK A1201 (-3.6A)0HK A1201 (-3.6A) | 0.64A | 4u14A-5dsgA:41.2 | 4u14A-5dsgA:67.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5hiw | CYTOCHROME P450CYP260B1 (Sorangiumcellulosum) |
PF00067(p450) | 5 | ILE A 298THR A 232ALA A 275ALA A 276TYR A 63 | NoneHEM A 401 (-3.7A)HEM A 401 ( 4.1A)NoneHEM A 401 (-4.4A) | 1.45A | 4u14A-5hiwA:undetectable | 4u14A-5hiwA:23.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5hw3 | BETA-LACTAMASE (Burkholderiavietnamiensis) |
PF13354(Beta-lactamase2) | 5 | ILE A 220TYR A 245THR A 161ALA A 184ALA A 187 | None | 1.49A | 4u14A-5hw3A:undetectable | 4u14A-5hw3A:20.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5jsc | PUTATIVE ACYL-COADEHYDROGENASE (Paraburkholderiaxenovorans) |
PF00441(Acyl-CoA_dh_1)PF02770(Acyl-CoA_dh_M)PF02771(Acyl-CoA_dh_N) | 5 | ILE A 367SER A 261ALA A 327ALA A 330TYR A 373 | NoneNoneNoneNoneFAD A 500 (-4.7A) | 1.31A | 4u14A-5jscA:3.4 | 4u14A-5jscA:21.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5m6q | UNCHARACTERIZEDPROTEIN (Kutzneriaalbida) |
PF09017(Transglut_prok) | 5 | ASP A 182TRP A 178ALA A 125ALA A 223ASN A 82 | None | 1.44A | 4u14A-5m6qA:undetectable | 4u14A-5m6qA:18.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5mfa | MYELOPEROXIDASE (Homo sapiens) |
PF03098(An_peroxidase) | 5 | ILE A 579ASP A 308ALA A 229ALA A 227ASN A 232 | None | 1.24A | 4u14A-5mfaA:undetectable | 4u14A-5mfaA:20.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5x7h | CYCLOISOMALTOOLIGOSACCHARIDEGLUCANOTRANSFERASE (Paenibacillussp. 598K) |
PF13199(Glyco_hydro_66)PF16990(CBM_35) | 5 | ASP A 59TYR A 55SER A 113THR A 135ALA A 123 | None | 1.48A | 4u14A-5x7hA:undetectable | 4u14A-5x7hA:20.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6bgi | ANOCTAMIN-1 (Mus musculus) |
no annotation | 5 | THR A 535ALA A 538ALA A 517ASN A 542TYR A 594 | None | 1.07A | 4u14A-6bgiA:3.2 | 4u14A-6bgiA:11.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6bk1 | UDP-GLYCOSYLTRANSFERASE 79 (Oryza sativa) |
no annotation | 5 | ILE A 389ASP A 385THR A 196ALA A 192ALA A 191 | None | 1.49A | 4u14A-6bk1A:undetectable | 4u14A-6bk1A:10.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6c26 | DOLICHYL-DIPHOSPHOOLIGOSACCHARIDE--PROTEINGLYCOSYLTRANSFERASESUBUNIT STT3 (Saccharomycescerevisiae) |
no annotation | 5 | ILE A 253TYR A 203SER A 206ALA A 169ALA A 171 | EGY C 301 ( 4.7A)EGY C 301 (-4.6A)EGY C 301 ( 3.9A)NoneNone | 1.37A | 4u14A-6c26A:undetectable | 4u14A-6c26A:10.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6gi2 | FERRIC ENTEROBACTINESTERASE (Pseudomonasaeruginosa) |
no annotation | 5 | SER A 29THR A 104ALA A 125ALA A 127TYR A 88 | None | 1.35A | 4u14A-6gi2A:undetectable | 4u14A-6gi2A:12.59 |